RITUXIMAB-ARRX vs RIZATRIPTAN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RITUXIMAB-ARRX vs RIZATRIPTAN: Safety Overview
| Metric | RITUXIMAB-ARRX | RIZATRIPTAN |
|---|---|---|
| Total FAERS Reports | 347 | 2,896 |
| Deaths Reported | 11 | 68 |
| Death Rate | 3.2% | 2.3% |
| Hospitalizations | 21 | 479 |
| Average Patient Age | 57.0 yrs | 44.6 yrs |
| % Female Patients | 60.6% | 77.2% |
| FDA Approval Date | N/A | Apr 14, 2023 |
| Manufacturer | N/A | Panacea Biotec Limited |
| Route | N/A | ORAL |
| Marketing Status | Prescription | Discontinued |